EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Recurrent Metastatic Basal Cell Carcinomas of the Face in a Patient with Gorlin–Goltz Syndrome

Petko Petrov, Dobromira Shopova iD, Georgi Goranov, Atanaska Dinkova iD, Nina Stoyanova, Nikolay Yanev iD

Current Oncology · 2025

DOI: 10.3390/curroncol32040193 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Current Oncology, 2025. Verfasst von Petko Petrov und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Maxillofacial Surgery, Faculty of Dental Medicine, Medical University-Plovdiv, 4000 Plovdiv, Bulgaria. Hauptthemen laut MEDLINE: Basal Cell Nevus Syndrome, Basal Cell Carcinoma, Neoplasm Recurrence, Local, Skin Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gorlin–Goltz syndrome, also known as nevoid basal cell carcinoma syndrome (NBCCS), is a rare, inherited autosomal dominant disorder primarily caused by mutations in the PTCH1 gene, which regulates the Hedgehog signaling pathway. This genetic defect leads to the uncontrolled proliferation of basal cells, resulting in the formation of multiple basal cell carcinomas (BCCs) and odontogenic keratocysts (OKCs). This study aims to present a complex clinical case of a patient with Gorlin–Goltz syndrome who developed multiple recurrent metastatic basal cell carcinomas on the facial region, detailing the multidisciplinary treatment strategies employed and the challenges encountered during the management of the disease. The patient, diagnosed with a pathogenic PTCH1 gene mutation, underwent a series of treatment interventions over several years. These included multiple surgical excisions aimed at tumor removal, diverse radiotherapy approaches for residual or inoperable lesions, and systemic targeted therapy with Hedgehog pathway inhibitors to control tumor progression. The recurrent and aggressive nature of the basal cell carcinomas resulted in extensive facial tissue loss, posing significant challenges for radical tumor excision and subsequent reconstructive procedures. Multimodal therapeutic strategies, including Mohs micrographic surgery for precise tumor clearance and targeted systemic therapy with vismodegib, were implemented. However, the aggressive progression of lesions required ongoing surgical interventions, highlighting the limitations of current treatment modalities in achieving long-term disease control. This case underscores the critical need for a comprehensive, multidisciplinary approach to managing Gorlin–Goltz syndrome. Successful management requires close collaboration between dermatologists, oncologists, maxillofacial surgeons, and plastic surgeons to balance effective tumor control with optimal functional and aesthetic outcomes. The integration of advanced surgical techniques and targeted molecular therapies shows promise in improving patient outcomes. Nonetheless, early diagnosis, rigorous follow-up, and patient education remain essential components in minimizing disease progression and enhancing the quality of life for affected individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basal Cell Nevus SyndromeBasal Cell CarcinomaNeoplasm Recurrence, LocalSkin NeoplasmsHumans

Stichwörter der Autor:innen

Gorlin–Goltz syndrome (GGS)basal cell carcinoma syndrome (NBCCS)basal cell carcinomas (BCCs)metastatic basal cell carcinomas (BCCs)

Autor:innen und Institutionen

  • Department of Maxillofacial Surgery, Faculty of Dental Medicine, Medical University-Plovdiv, 4000 Plovdiv, Bulgaria.
  • Department of Prosthetic Dentistry, Faculty of Dental Medicine, Medical University-Plovdiv, 4000 Plovdiv, Bulgaria.
  • Section Cardiology, First Department of Internal Diseases, Medical University-Plovdiv, 4000 Plovdiv, Bulgaria.
  • Department of Oral Surgery, Faculty of Dental Medicine, Medical University-Plovdiv, 4000 Plovdiv, Bulgaria.
  • Department of Ophthalmology, Faculty of Medicine, Medical University-Plovdiv, 4000 Plovdiv, Bulgaria.
  • Department of Medical and Clinical-Diagnostic Activities, Ruse University "Angel Kanchev", 7000 Ruse, Bulgaria.

ORCID-Profile: Dobromira Shopova, Atanaska Dinkova, Nikolay Yanev

Zitieren

APA

Petrov, P., Shopova, D., Goranov, G., Dinkova, A., Stoyanova, N., & Yanev, N. (2025). Recurrent Metastatic Basal Cell Carcinomas of the Face in a Patient with Gorlin–Goltz Syndrome. Current Oncology. https://doi.org/10.3390/curroncol32040193

Vancouver

Petrov P, Shopova D, Goranov G, Dinkova A, Stoyanova N, Yanev N. Recurrent Metastatic Basal Cell Carcinomas of the Face in a Patient with Gorlin–Goltz Syndrome. Current Oncology. 2025. doi:10.3390/curroncol32040193

BibTeX
@article{Petrov2025,
  author = {Petrov, Petko and Shopova, Dobromira and Goranov, Georgi and Dinkova, Atanaska and Stoyanova, Nina and Yanev, Nikolay},
  title = {Recurrent Metastatic Basal Cell Carcinomas of the Face in a Patient with Gorlin–Goltz Syndrome},
  journal = {Current Oncology},
  year = {2025},
  doi = {10.3390/curroncol32040193}
}
Kostenlos starten →